Resources

The Milner Therapeutics Institute has joined the o2h Discovery Platinum Partner Programme, enabling eligible companies within its bio-incubator and wider affiliate network to access specialist drug discovery support through the o2h Kickstarter Award.

Each month, our Policy and Public Affairs team will showcase how we are championing members’ voices in Government and Parliament.

Drug Discovery 2026 returns to ExCeL London from 14–15 October to celebrate 20 years of collaboration and inclusion. Keynote programme includes presentation from Dr Sam Barrell CBE and panel discussion with Dr Anne Phelan, Dr Jason Mellad, Prof Sir Mene Pangalos and Prof Raghib Ali OBE

POLB 001 cancer immunotherapy-induced CRS patent granted in Canada, further strengthening Poolbeg's global intellectual property portfolio

Significant milestone for Poolbeg's global intellectual property portfolio

In this blog, Jaime Eaton, reflects on this month's Community Connects series, bringing together diverse expertise to tackle the most pressing challenges in our sector.

The BioIndustry Association (BIA) is pleased to announce the appointment of Will James, partner at Osborne Clarke LLP, as Vice-Chair of its Intellectual Property Advisory Committee (IPAC).

The Cell and Gene Therapy Catapult is launching a Technology Advisory Board to accelerate the UK’s leadership in advanced therapies.

Professor Cathy Tralau-Stewart, Executive Director of the Milner Therapeutics Institute, has continued her thought leadership work with an article in Drug Discovery World.

Stablepharma will apply its proprietary stabilisation technology, initially focused on vaccines, to non-vaccine sterile injectables that currently require cold-chain storage. Stablepharma will be eligible to receive future milestone and royalty revenue from AFT upon commercialisation.

LifeArc and the Gates Foundation are funding seven ground-breaking new projects launched to lower the cost of monoclonal antibody production to make them more accessible globally.

In this blog, Justin Wilson, Withers & Rogers LLP, shares his expert perspective on what the recent patent rulings from the Unified Patent Court (UPC) and the Court of Justice of the European Union (CJEU) mean in practice for biotech and pharma companies.

The fourth edition of the Tech Kickstarter Competition is now open for applications. If you are a seed or early-stage company working on a breakthrough product in life sciences, green tech, or tech/AI, this is your chance to accelerate your tech development.

The new site reflects Stratagem’s growth as a forward-thinking IP partner, offering clarity, simplicity and relevance across every stage of the client journey.